Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
RedHill Biopharma (RDHL)
NASDAQ:RDHL
Holding RDHL?
Track your performance easily
RDHL Stock Chart & Stats
Day’s Range― - ―
52-Week Range$5.41 - $31.50
Previous CloseN/A
Volume5.64K
Average Volume (3M)15.66K
Market Cap
$7.26M
Enterprise ValueN/A
Total Cash (Recent Filing)$66.15M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.15
Next Earnings
Mar 13, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding1,274,680
10 Day Avg. Volume10,142
30 Day Avg. Volume15,656
Standard Deviation0.53
R-Squared0.13
Alpha-0.07
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.12
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
RedHill Biopharma News
PremiumCompany Announcements
RedHill Biopharma Advances Opaganib for GI-ARS Treatment
PremiumCompany Announcements
RedHill Biopharma Wins $8 Million Court Judgment
PremiumCompany Announcements
RedHill Biopharma to Present Opaganib at U.S. Defense Conference
PremiumCompany Announcements
RedHill Biopharma and Duke Collaborate on Opaganib Development
PremiumCompany Announcements
RedHill Biopharma Partners with BARDA for Ebola TreatmentOwnership Overview
―
Insiders
<0.01% Mutual Funds
― Other Institutional Investors
100.00% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
RDHL FAQ
What was RedHill Biopharma’s price range in the past 12 months?
RedHill Biopharma lowest stock price was $5.41 and its highest was $31.50 in the past 12 months.
What is RedHill Biopharma’s market cap?
RedHill Biopharma’s market cap is $7.26M.
When is RedHill Biopharma’s upcoming earnings report date?
RedHill Biopharma’s upcoming earnings report date is Mar 13, 2025 which is in 51 days.
How were RedHill Biopharma’s earnings last quarter?
Currently, no data Available
Is RedHill Biopharma overvalued?
According to Wall Street analysts RedHill Biopharma’s price is currently Overvalued.
Does RedHill Biopharma pay dividends?
RedHill Biopharma does not currently pay dividends.
What is RedHill Biopharma’s EPS estimate?
RedHill Biopharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does RedHill Biopharma have?
RedHill Biopharma has 1,274,680 shares outstanding.
What happened to RedHill Biopharma’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of RedHill Biopharma?
Currently, no hedge funds are holding shares in RDHL
---
Company Description
RedHill Biopharma
RedHill Biopharma Ltd. is a specialty biopharmaceutical company primarily focused on the development and commercialization of late clinical-stage, proprietary drugs for the treatment of gastrointestinal diseases. It operates through two segments: Commercial Operations and Research & Development. The Commercial Operations segment covers all areas relating to the commercial sales and operating expenses directly related to that activity and is being performed by the Company's U.S. subsidiary. The Research and Development segment includes all activities related to the research and development of therapeutic candidates and is being performed by the Company. The company was founded by Dror Ben-Asher and Ori Shilo on August 3, 2009 and is headquartered in Tel Aviv, Israel.
---
Technical Analysis
ESSA Pharma
―
TuHURA Biosciences
―
Bioxcel Therapeutics
―
Cyclerion Therapeutics
―
Kazia Therapeutics
―
BioVie
―
---